期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

弥漫大B细胞淋巴瘤预后相关因素研究进展 被引量：4

下载PDF
导出
摘要 0引言弥漫大B细胞淋巴瘤（diffuse large B-cell lym-phoma,DLBCL）是成人非霍奇金淋巴瘤（non-Hodgkin lymphoma,NHL）中最常见的类型,占NHL的30%～40%,它是一类在细胞遗传学、分子学、临床表现及疾病转归方面异质性均明显的疾病,利妥昔单抗（Rituximab）联合CHOP化疗使患者的5年OS（over all
作者 赵茜 侯健
机构地区 第二军医大学长征医院血液科全军骨髓瘤与淋巴瘤疾病中心
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第6期514-516,共3页 Cancer Research on Prevention and Treatment
关键词 弥漫大B细胞淋巴瘤 预后 肿瘤微环境
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expressionprofiling[J]. Nature, 2000, 403(6769): 503-11.
  • 2Hans CP, Weisenburger DD, Greiner TC, etal, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohitochemistry using a tissue microarray[J]. Blood, 2004, 103(1) : 275-82.
  • 3Choi WW, Weisenburger DE), Greiner TC, et al. A new im- munostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy[J]. Clin Cancer Res, 2009, 15(17): 5494-502.
  • 4Meyer PN, Fu K, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab[J]. J Clin Oncol, 2011, 29(2): 200-7.
  • 5Ott G, Ziepert M, Klapper W,et al. Immunoblastic morphol- ogy but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL[J]. Blood, 2010, 116 (23) : 4916-25.
  • 6Lenz G, Wrigh G, Dave SS, et al. Stromal gene signatures in large B-cell lymphomas[J]. N Engl J Med, 2008, 359 (22) 2313-23.
  • 7Evens AM, Sehn LH, Farinha P, et al. Hypoxia-inducible factor-1 a expression predicts superior survival in patients with diffuse large b-cell lymphoma treated with R-CHOP[J]. J Clin Oncol, 2010, 28(6): 1017-24.
  • 8Cai QC, Liao H, Lin SX, etal. High expression of tumor-in- filtrating macrophages correlates with poor prognosis in pa- tients with diffuse large B-cell lymphoma[J]. Med Oncol, 2012, 29(4): 2317-22.
  • 9Gratzinger D, Zhao S, Tihshirani RJ, etal. Prognostic signifi- cance of VEGF, VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy[J]. Lab Invest, 2008, 88(1) : 38-47.
  • 10Riihij rvi S, Nurmi H, Holte H, et al. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy[J]. Eur J Haematol,2012, 89(5): 395-402.

同被引文献65

  • 1张晓艳,李建勇,吴汉新,陆化,钱思轩,吴雨洁,徐卫,洪鸣,张闰.利妥昔单抗联合自体外周血干细胞移植治疗非霍奇金淋巴瘤[J].中国新药与临床杂志,2006,25(7):541-544. 被引量：3
  • 2Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prog- nostic Index (NCCN- IPI) for patients with diffuse large B- cell lym- phoma treated in the rituximab era[J ]. Blood, 2014,123 (6): 837 -842.
  • 3Achenbach C J, Buchanan AL, Cole SR, et al. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy[J]. Clin Infect Dis, 2014, 58(11): 1599-606.
  • 4Vendrame E, Hussain SK, Breen EC, et al. Serum levels of cytokines and biomarkers for inflammation and immune activation, and H1V-associated non-Hodgkin B-Cell lymphoma risk[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(2): 343-9.
  • 5Gopal S, Patel MR, Yanik EL, et aL Temporal Trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy Era[J]. J Natl Cancer lnst, 2013, 105(16): 1221-9.
  • 6Shiels MS, Engels EA, Linet MS, et al. The epidemic of non- Hodgkin lymphoma in the United States:disentangling the effect of HIV, 1992-2009[J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(6): 1069-78.
  • 7Kandala NB, Campbell EK, Rakgoasi SD, et al. The geography of HIV/AIDS prevalence rates in Botswana[J]. HIV AIDS (Auckl), 2012, 4: 95-102.
  • 8Ambinder RF, Bhatia K, Martinez-Maza O, et al. Cancer Biomarkers in HIV patients[J]. Curt Opin HIV AIDS, 2010, 5(6): 531-7.
  • 9Biggar R J, Chaturvedi AK, Goedert J J, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS[J]. J Natl Cancer Inst, 2007, 99(12): 962472.
  • 10Dhir AA, Sawant S, Dikshit RP, et al. Spectrum of HIV/ AIDS related cancers in India[J]. Cancer Causes Control, 2008, 19(2): 147-53.

引证文献4

二级引证文献22

肿瘤防治研究
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部